Condition: Healthy Adult Participants · Hepatic Impairment (HI) · Sponsor: InventisBio Co., Ltd
This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.
This description comes directly from the study's public registry record.
Huan Zhou · +86 0552-3085747 · zhouhuanbest@vip.163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, Anhui, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07715149